COAG

Conviction 100HealthcareScan · Thu, Sep 24, 2026

Hemab Therapeutics Holdings, Inc. (COAG) closed at $35.79 (-2.56%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 30, -34.9% from its 52-week high, +5.3% year to date. Sector: Healthcare · Biotechnology.

COAG$35.79-2.56%

ResistanceSupportVol 14Insider buy

Vol MA14 782.03K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Hemab Therapeutics Holdings, Inc.Biotechnologywww.hemab.com ↗

Price35.79

Change-2.56%

Gap+0.56%

Rel volume2.71×

Avg volume652.8K

Avg $ vol26.75M

SMA 2041.93

SMA 5046.36

SMA 200—

Price vs 50-22.80%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 45.36

RSI (14)30

MACD hist-0.62

MACD cross—

Stoch %K / %D15 / 13

ADX (14)24

+DI / −DI10 / 25

RSI divergence—

MACD divergenceBullish

ATR %9.45%

ADR %7.70%

52w high54.94

52w low24.98

From 52w high-34.86%

Above 52w low+43.27%

New 52w highNo

SqueezeOff

Bollinger width32.33%

%B0.05

Donchian pos10.54%

Donchian high51.11

Donchian low33.99

AVWAP (52w high)42.79

vs AVWAP high-16.37%

AVWAP (52w low)40.04

vs AVWAP low-10.60%

OBV trendDown

Chaikin MF (20)-0.27

Today vs 20d2.71×

Avg vol (14d)782.03K

Avg vol (20d)652.8K

Avg $ vol (20d)26.75M

Market cap1.67B

RS Rating—

RS 3m (vs SPY)+24.62%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank7.2

1 week-13.17%

1 month-27.92%

3 months+29.11%

6 months—

1 year—

YTD+5.26%

P/E—

P/B3.68

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current35.85

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target54.25

Target upside51.58%

Analyst ratingBuy

Institutional77.62%

Ent. value1.43B

Revenue—

Net income-24.15M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out46.71M

Employees—

ListedFri, May 1, 2026

Free float15.97M

Float %40.7%

Short interest2.11M

Days to cover6.0d

Short volume59.5%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.80 vs −$0.63

Last surprise-27.0% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank7.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance54.52

Support40.75

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COAG

All disclosures →

No recent disclosed trades by Congress in COAG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COAG · open-market 7 buys

Insider	Side	Shares	Value	Traded	Filed
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Kolchinsky Peter 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21

SEC filings

EDGAR filings in COAG · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.